CSF2 and cancer: Moreover, when a VSV-Δ51 expressing granulocyte macrophage-colony stimulating factor (GM-CSF) was used for the ICV, potent activation of both NK cells and T cells was observed in addition to tumor debulking and long-term cancer surveillance [49].